Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management
- 1 October 2006
- journal article
- Published by Elsevier BV in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
- Vol. 102 (4), 433-441
- https://doi.org/10.1016/j.tripleo.2006.06.004
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myelomaBritish Journal of Haematology, 2005
- Bisphosphonate-associated oral osteonecrosisOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2005
- Intravenous bisphosphonates and osteonecrosisOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2004
- Osteonecrosis of the jaws associated with the use of bisphosphonate medications: a report of 60 casesOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2004
- Osteonecrosis and bisphosphonates: correlation versus causationJournal of Oral and Maxillofacial Surgery, 2004
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Osteonecrosis of the maxilla and mandible: possible drug-induced complication of bisphosphonate therapyOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2004
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Osteonecrosis of the jaws associated with the use of bisphosphonatesJournal of Oral and Maxillofacial Surgery, 2003